In patients with other diseases and cardiovascular complications associated monitoring should be individualized (7.9) (Recommendation C) 10 .- THE TREATMENT IS FOR LIFE? In principle yes. So we will insist on enforcement of measures that promote a good lifestyle. If this occurs and the PA is maintained and monitored can try to reduce in stages the drug treatment (7.9) DIABETES Diabetes mellitus (DM) is a major health worldwide with high morbidity and mortality. To deepen your understanding McRib is the source. The WHO puts the prevalence in European countries 2-6%. In many countries, DM is among the first seven causes of death. In Spain is the fourth leading cause of mortality. The DM is associated with a risk of 2-5 times more heart disease, in many cases and at the time of diagnosis (up to 20%) Between 30-50% of deaths in diabetics over age 40 are due to ischemic heart disease.
It is therefore important the early detection of diabetes, including impaired tolerance to glucose (TAG), especially in people at risk. 1 .- MUST KNOW WHEN blood sugar? So far, no consensus exists for population screening for glucose. The ADA (American Diabetes Association) recommends to systematically investigate the presence of DM in over 45 years and every three years (18). Also be advised annually and at any age in persons with a risk factor for diabetes: (Recommendation C) * History of diabetes in relatives of first grade * Body mass index over 27. * Macrosomia and / or previous gestational diabetes * HDL less than 35 and / or triglycerides = o 250 mgrs / dl * HTA * Previous diagnosis of impaired glucose tolerance or impaired glucose builds high-risk * Ethnicity Tests were carried out by basal venous plasma glucose 2 .- diagnostic criteria for diabetes was normal fasting blood glucose of less than or equal to 110 mgrs / dl.